You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Summary of HIV care and treatment programmatic factors, by clusters

From: Identifying models of HIV care and treatment service delivery in Tanzania, Uganda, and Zambia using cluster analysis and Delphi survey

PROGRAMMATIC FACTORS CLUSTER 1 Traditional Model (n = 5 clinics) CLUSTER 2 Mixed Model (n = 10 clinics) CLUSTER 3 Task-Shifted Model (n = 4 clinics)
Clinic days Per Week (average clinic day is 7 h)
 Average number of clinic days at the main ART site (min, max) 4.6 (3,6) 4.4 (2,6) 4.8 (4,5)
 Average number of clinic days at outreach sites (min, max) 3.0 (0,5) 1.3 (0,5) 0.5 (0,2)
 Total average number of clinic days (min, max) 7.6 (3,11) 5.7 (4,10) 5.3 (5,6)
Time to ART initiation
  > 7 days to determine eligibility 0/5 (0%) 6/10 (60%) 2/4 (50%)
  > 7 days to initiate AT if found eligible 1/5 (20%) 4/10 (40%) 2/4 (50%)
 Site requires at least 3 counselling sessions before ART initiation 2/5 (40%) 9/10 (90%) 3/4 (75%)
 One or more stock out of ART in the past 6 months 1/5 (20%) 0/10 (0%) 4/4 (100%)
Time to Less Frequent ARV Drug Refill (every 2 months instead of monthly)
 In the first month on ART 0/5 (0%) 0/10 (0%) 0/4 (0%)
 Between two and six months on ART 0/5 (0%) 2/10 (20%) 0/4 (0%)
 After six months on ART 1/5 (20%) 8/10 (80%) 1/4 (25%)
Frequency of laboratory testing after 6 months on ART
 CD4 cell count    
  Every 3 months 1/5 (20%) 2/10 (20%) 0/4 (0%)
  Every 6 months 4/5 (80%) 8/10 (80%) 4/4 (100%)
 Viral load testing    
  Never 2/5 (40%) 6/10 (60%) 3/4 (75%)
  As needed 3/5 (60%) 4/10 (40%) 1/4 (25%)
Adherence support through the HIV care and treatment clinic
 Require treatment supporter after ART initiation 5/5 (100%) 8/10 (80%) 3/4 (75%)
 Pill count during 1st six months on ART 0/5 (0%) 5/10 (50%) 3/4 (75%)
 Pill count after 1st six months on ART 0/5 (0%) 5/10 (50%) 2/4 (50%)
 Pill count after patient misses ARV drug refill appointment 4/5 (80%) 7/10 (70%) 3/4 (75%)
 People Living with HIV support group 5/5 (100%) 8/10 (80%) 4/4 (100%)
 Adherence support worker 4/5 (80%) 8/10 (80%) 3/4 (75%)
 Home-based care worker 3/5 (60%) 5/10 (50%) 2/4 (50%)
Community-based services linked to the HIV care and treatment clinic
 ARV drug distribution by providers or lay volunteers 0/5 (0%) 3/10 (30%) 1/4 (25%)
 Adherence support 5/5 (100%) 8/10 (80%) 4/4 (100%)
 Emotional or social support 4/5 (80%) 8/10 (80%) 3/4 (75%)
 Follow-up of missed appointments 4/5 (80%) 7/10 (70%) 3/4 (75%)
 Nutritional supplementation 3/5 (60%) 5/10 (50%) 3/4 (75%)
 Home based care 4/5 (80%) 7/10 (70%) 4/4 (100%)
 Referral for medical care 4/5 (80%) 7/10 (70%) 4/4 (100%)
Follow-up of missed clinic or pharmacy appointment
 Telephone contact 4/5 (80%) 9/10 (90%) 4/4 (100%)
 House visit by adherence support worker 3/5 (60%) 8/10 (80%) 3/4 (75%)
 House visit by healthcare worker 1/5 (20%) 5/10 (50%) 1/4 (25%)
 House visit by home-based care worker 3/5 (60%) 7/10 (70%) 3/4 (75%)
Tracing of patients loss to follow-up
 Telephone contact 4/5 (80%) 9/10 (90%) 4/4 (100%)
 House visit by adherence support worker 4/5 (80%) 8/10 (80%) 2/4 (50%)
 House visit by healthcare worker 3/5 (60%) 5/10 (50%) 1/4 (25%)
 House visit by home-based care worker 3/5 (60%) 7/10 (70%) 1/4 (25%)